EVALUATION OF THE PHARMACOTHERAPEUTIC PROFI LE OF THE HYPERDIA GROUP IN THE FAMILY HEALTH UNIT

Authors

  • Clarissa Figueredo Braga Universidade Federal de Pernambuco Av. Prof. Moraes Rego, 1235 - Cidade Universitária, Recife - PE, 50670-901 http://orcid.org/0000-0002-3185-6253
  • Taynara Poliana Gonçalves de Melo Universidade de Pernambuco Av. Gov. Agamenon Magalhães - Santo Amaro, Recife - PE, 50100-010
  • José Gildo de Lima Universidade Federal de Pernambuco Av. Prof. Moraes Rego, 1235 - Cidade Universitária, Recife - PE, 50670-901

DOI:

https://doi.org/10.14450/2318-9312.v32.e2.a2020.pp144-152

Keywords:

hypertension, diabetes mellitus, primary health care, medication adherence

Abstract

One of the most important factors for controlling hypertension and diabetes is adherence to pharmacological treatment. This is a crossectional research with quantitative approach conducted at Family Health Unit Casarão do Cordeiro in Recife, PE, from May to July 2019. According to the results, 72.5% of Hiperdia users were women and most are over 50 years old. Hypertension was the most prevalent condition among participants. There was a high rate of people taking fi ve or more medications. About 90% said they knew that diabetes and hypertension are chronic diseases that can be controlled with diet and medication, but most do not know which organs can be aff ected by these diseases. Only 17.7% demonstrated to follow the treatment correctly. About 57% of the participants had their blood pressure (BP) altered at the time, which may be directly related to low adherence to treatment. Thus, the importance of developing interdisciplinary health education actions for the management and better control of hypertension and diabetes in such patients is evident. 

Author Biographies

Clarissa Figueredo Braga, Universidade Federal de Pernambuco Av. Prof. Moraes Rego, 1235 - Cidade Universitária, Recife - PE, 50670-901

Farmacêutica formada pela Universidade Federal de Pernambuco. Com especialização em Saúde da Família. Atualmente está vinculada ao programa de Residência em Saúde Coletiva com ênfase em Gestão de Redes.

Taynara Poliana Gonçalves de Melo, Universidade de Pernambuco Av. Gov. Agamenon Magalhães - Santo Amaro, Recife - PE, 50100-010

Graduada no curso de Bacharelado em Educação Física pela Universidade Federal de Pernambuco/Centro Acadêmico de Vitória. Possui especialização em Saúde Mental. Atualmente é Residente Multiprofissional em Saúde da Família com ênfase na Saúde do Campo - FCM/UPE.

José Gildo de Lima, Universidade Federal de Pernambuco Av. Prof. Moraes Rego, 1235 - Cidade Universitária, Recife - PE, 50670-901

Possui graduação em Farmácia pela Universidade Federal de Pernambuco (1984), mestrado em Ciências Farmacêuticas pela Universidade Federal de Pernambuco (1988) e doutorado em Doctorat En Pharmacie - Universite de Grenoble I (Scientifique Et Medicale - Joseph Fourier) (1992). Atualmente é professor associado 4 da Universidade Federal de Pernambuco. Tem experiência na área de Farmácia, com ênfase em Química Medicinal e Síntese Orgânica, atuando principalmente nos seguintes temas: antimicrobianos, 4-tiazolidinonas, toxoplasmose, antineoplásicos e AINES. Participa como tutor do Programa de Residência Multiprofissional em Saúde da Família da UFPE.

Downloads

Published

2020-07-07

How to Cite

Figueredo Braga, C., Gonçalves de Melo, T. P., & de Lima, J. G. (2020). EVALUATION OF THE PHARMACOTHERAPEUTIC PROFI LE OF THE HYPERDIA GROUP IN THE FAMILY HEALTH UNIT. Infarma - Pharmaceutical Sciences, 32(2), 144–152. https://doi.org/10.14450/2318-9312.v32.e2.a2020.pp144-152

Issue

Vol. 32 No. 2 (2020)

Section

Original article

License

Authors who publish in this journal agree to the following terms:

 

  1. Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
  2. Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
  3. Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).